SKLB0565 is a potent tubulin inhibitor with significant antiproliferative activity against colorectal cancer cells (IC50 range: 0.012–0.081 μM); it induces G2/M phase arrest and mitochondria-mediated intrinsic apoptosis, inhibits cell migration, and disrupts microtubule formation in HUVECs.